Categories: Business

Mattress Tub and Past will get a uncommon buy ranking, however 2 merchants would not chew

Bed Bath and Beyond can be out of reach.

Although the retailer received a rare buy rating this week from B. Riley, who initiated the name with a price target of $ 44 and an upbeat argument for its new management and cost-cutting strategies, the stock doesn’t look particularly attractive at its current levels, two shared Traders on Thursday with CNBC’s “Trading Nation”.

The $ 3.5 billion company’s earnings and revenue growth forecasts may look better than those of its industry peers, but it still falls short compared to the broader market, Gina Sanchez, founder and CEO of Chantico Global, said in an interview on Thursday.

“It’s really hard to get upset,” she said. “We think they’re the right price and that’s not necessarily a screaming buy.”

Bed Bath and Beyond has already risen 78% since the beginning of the year and is trading at a multiple of almost 20.5 times the forward price / earnings ratio.

The history of the stock as a Reddit favorite is also doing investors a disservice, Sanchez said.

“Once that momentum takes hold in the market, you’re pretty late because these momentum trades on some of these meme stocks have nothing to do with fundamentals,” she said. “If you buy it just for the momentum, that’s the worst reason to buy because you will inevitably be the bigger fool in this story.”

One possibility that could develop has to do with Bed Bath and Beyond’s brief interest, said Matt Maley, chief marketing strategist at Miller Tabak, in the same “Trading Nation” interview.

Both times this year the stock got swept up in Reddit trading – first when GameStop rallied in January and again when AMC skyrocketed in June – it had remarkably high short interest, Maley said.

Zoom In Icon Arrows pointing outwards

“Now it’s down again. If anything, it’s got incredibly low short interest, not a high one. So people have to be very, very careful,” warned Maley. “If we … get another short squeeze, Bed Bath and Beyond won’t be one of the stocks being squeezed like that.”

While the company’s recovery history may sound promising, it will likely take time for the stock to reflect, the strategist said.

“They’ve made some good changes and their revenue has been pretty good, but I just don’t think people should be looking for another rocket ship like we’ve seen twice this year,” he said hey.

Disclaimer of Liability

Jimmy Page

MV Telegraph Writer Jimmy Page has been writing for all these 37 years.

Recent Posts

The Vertex kidney drug povetacicept is profitable within the examine for IgAN

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston.Brian Snyder…

7 hours ago

The federal government ought to present extra help to Individuals caught within the Center East

Senator Elizabeth Warren (D-MA), accompanied by Senator Angus King (I-ME) (L), speaks as General Gregory…

19 hours ago

Los Angeles Marathon about Michael Kimani Kamau Unsuitable flip, no winner

The LA Marathon also congratulated all of the race's podium finishers - including Enyew Nigatwho…

3 days ago

US Treasury yields: Oil returns larger

The 10-year Treasury Department The yield initially rose before falling on Monday as oil prices…

4 days ago

FDA’s vaccine chief will resign in April after a sequence of controversial choices

The Food and Drug Administration logo is seen before a news conference at Health and…

4 days ago

Within the booming enterprise of wellness golf equipment and third areas

A few years ago, Grace Guo began to long for places in New York City…

5 days ago

This website uses cookies.